Chicago Atlantic Provides $16.5 Million Term Loan to Ocular Science, Inc., a Leading Biotech Company Focused on Compounded Ophthalmic Products

CHICAGO--(BUSINESS WIRE)--Chicago Atlantic announced its role as sole arranger and administrative agent in the closing of a $16.5 million senior secured term loan for Ocular Science, Inc. (“Ocular Science”), an affiliate of OSRX, Inc. OSRX is a leading provider of compounded ophthalmic medications. Founded in 2015 and guided by a medical advisory board of 31 world leaders in ophthalmology, Ocular Science focuses on the production of paradigm-shifting therapeutic solutions for eye care that are